Article
Expression and prognostic role of E2F transcription factors in high‐grade glioma
16 Feb 2020
Abstract excerpt
INTRODUCTION: Patients with high-grade glioma (HGG) suffered poor survival due to inherent or acquired therapeutic resistance and refractory recurrence. The outcome of HGG patients has improved little during the past decade. Therefore, molecular signatures are urgently needed for improving diagnosis, survival prediction and identification of therapeutic targets for HGG. E2F transcription factors (E2Fs), a family...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
